Trials / Completed
CompletedNCT03049059
A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Mae Fah Luang University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A Comparative study for Efficacy and Safety Between 4% hydroquinone cream with or without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma
Detailed description
Primary Objective: * To compare clinical efficacy by Modified MASI score between Fractional Picosecond 1,064 nm laser and daily application of 4% hydroquinone with 4% hydroquinone alone Secondary objectives * To compare the clinical endpoints of Mexameter Melanin Index, brownish spot and Ultraviolet spots by VISIATM complexion analysis, The Antera 3D® imaging technology for pigmentation, quality of life by Dermatology Life Quality Index and patient's satisfaction between Fractional Picosecond 1,064 nm laser and 4% hydroquinone with 4% hydroquinone alone
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fractional Picosecond 1,064 nm laser | Fractional Picosecond 1,064 nm laser and daily application with 4% hydroquinone cream |
| DRUG | 4% hydroquinone cream |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-12-01
- Completion
- 2017-02-01
- First posted
- 2017-02-09
- Last updated
- 2017-02-09
Source: ClinicalTrials.gov record NCT03049059. Inclusion in this directory is not an endorsement.